(IQLT) iShares MSCI Intl Quality - Ratings and Ratios
International, Large-Cap, Mid-Cap, Quality, Stocks
Dividends
| Dividend Yield | 2.32% |
| Yield on Cost 5y | 3.41% |
| Yield CAGR 5y | 16.81% |
| Payout Consistency | 95.2% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 12.8% |
| Value at Risk 5%th | 21.4% |
| Relative Tail Risk | 1.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.82 |
| Alpha | 6.65 |
| CAGR/Max DD | 1.03 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.332 |
| Beta | 0.627 |
| Beta Downside | 0.581 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.18% |
| Mean DD | 2.81% |
| Median DD | 2.01% |
Description: IQLT iShares MSCI Intl Quality October 30, 2025
The iShares MSCI International Quality Factor ETF (IQLT) commits at least 80% of its capital to the securities that compose its benchmark, the MSCI World Quality Index. This index targets large- and mid-cap stocks in developed markets that score high on three fundamental quality metrics: return on equity (ROE), low earnings variability, and modest debt-to-equity ratios.
As of the latest filing, IQLT carries an expense ratio of 0.30% and manages roughly $1.2 billion in assets, with its top holdings concentrated in consumer staples (e.g., Nestlé), health care (e.g., Roche) and technology (e.g., SAP). The fund’s sector tilt toward low-cyclical industries can provide a defensive edge when global growth slows, while its quality screen tends to favor companies with stronger cash-flow generation-an advantage in a rising-rate environment that pressures highly leveraged firms.
For a deeper, data-driven view of IQLT’s risk-adjusted performance and how its quality tilt interacts with macro-economic variables, you might explore the analytics platform ValueRay, which offers granular factor breakdowns and scenario modeling.
What is the price of IQLT shares?
Over the past week, the price has changed by +0.83%, over one month by +1.67%, over three months by +3.06% and over the past year by +16.87%.
Is IQLT a buy, sell or hold?
What are the forecasts/targets for the IQLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 51.2 | 13.5% |
IQLT Fundamental Data Overview December 05, 2025
Beta = 1.11
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 13.29b USD (13.29b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 13.29b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 13.29b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.33% (E(13.29b)/V(13.29b) * Re(8.33%) + (debt-free company))
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IQLT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle